000	00000nam 2200000zi 4500
001	9.954398
003	CaOODSP
005	20250825114148
006	m     o  d f
007	cr cn|||||||||
008	250822e20160120oncd    obs  f000 0 eng d
040	|aCaOODSP|beng|erda|cCaOODSP
043	|an-cn---
086	1 |aCS82-003/2016-1-3E-PDF
100	1 |aHennessy, Deirdre A., |eauthor.
245	10|aPopulation health impact of statin treatment in Canada / |cby Deirdre A. Hennessy, Peter Tanuseputro, Meltem Tuna, Carol Bennett, Richard Perez, Margot Shields, Dennis T. Ko, Jack Tu and Douglas G. Manuel.
264	1|a[Ottawa] : |bStatistics Canada = Statistique Canada, |cJanuary 20, 2016.
264	4|c©2016
300	|a1 online resource (pages 20-28).
336	|atext|btxt|2rdacontent
337	|acomputer|bc|2rdamedia
338	|aonline resource|bcr|2rdacarrier
490	1 |aHealth reports, |x1209-1367 ; |vvol. 27, no. 1, [3]
500	|aIssued also in French under title: Incidence du traitement aux statines sur la santé de la population au Canada
500	|aCover title.
504	|aIncludes bibliographical references (page 27-28).
520	3 |a"Statins are prescribed to treat dyslipidemia (abnormal amount of lipids such as cholesterol and/or fat in the blood) and reduce cardiovascular disease (CVD) risk. This study describes the CVD risk profile of Canadians aged 20 to 79, compares current treatment patterns with guideline recommendations, and investigates the population health impact of statin treatment"--Abstract, page 20.
650	0|aStatins (Cardiovascular agents)|zCanada|vStatistics.
650	0|aCardiovascular system|xDiseases|zCanada.
655	7|aStatistics|2lcgft
710	2 |aStatistics Canada, |eissuing body.
775	08|tIncidence du traitement aux statines sur la santé de la population au Canada / |w(CaOODSP)9.954397
830	#0|aHealth reports (Series)|x1209-1367 ; |vvol. 27, no. 1, [3].|w(CaOODSP)9.950253
856	40|qPDF|s611 KB|uhttps://publications.gc.ca/collections/collection_2025/statcan/82-003-x/CS82-003-2016-1-3-eng.pdf
856	4 |qHTML|sN/A|uhttps://www150.statcan.gc.ca/n1/pub/82-003-x/2016001/article/14305-eng.htm
986	|a82-003-X